Ng, Heng Joo
Alata, Maaz Kamal
Nguyen, Quang The
Huynh Duc Vinh, Phu
Tan, Jing Yuan
Wong, Chieh Lee
Article History
Received: 8 April 2024
Accepted: 18 May 2024
First Online: 4 June 2024
Declarations
:
: Following the International Committee of Medical Journal Editors’ (ICMJE) guidelines, Heng Joo Ng and Chieh Lee Wong report receiving consulting fees and honoraria for lectures and presentations from AstraZeneca. Quang The Nguyen reports receiving consulting fees from AstraZeneca. Phu Huynh Duc Vinh reports receiving consulting fees and honoraria for lectures and presentations from AstraZeneca and Novartis. Maaz Kamal Alata reports receiving honoraria for lectures and presentations for AstraZeneca, Pfizer, and Astellas Pharma. Additionally, he reports receiving meeting attendance support from Astellas Pharma, NewBridge Pharmaceuticals, Merck, and Gilead. Jing Yuan Tan has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants, or patents received or pending, or royalties.